Concepedia

Publication | Closed Access

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

90

Citations

22

References

2002

Year

Wouter A.P. Breeman, Marion de Jong, Jack L. Erion, Joseph E. Bugaj, Ananth Srinivasan, Bert F. Bernard, Dik J. Kwekkeboom, Theo J. Visser, Eric P. Krenning
PubMed

Abstract

[(111)In-DTPA-Pro(1),Tyr(4)]BN is a promising radioligand for scintigraphy of GRP receptor-expressing tumors. We are currently performing a phase I study on patients with invasive prostate carcinoma.

References

YearCitations

Page 1